230 likes | 507 Views
Correlation study between post- bronchodialator FEV 1 and six minute walk distance in chronic obstructive pulmonary disease patients. Dr Arnab Maji Dr Avijit Kundu Prof. (Dr) Supriya Sarkar Dept of Respiratory Medicine N.R.S. Medical College, Kolkata. Introduction .
E N D
Correlation study between post-bronchodialator FEV1 and six minute walk distance in chronic obstructive pulmonary disease patients Dr ArnabMaji Dr AvijitKundu Prof. (Dr) SupriyaSarkar Dept of Respiratory Medicine N.R.S. Medical College, Kolkata
Introduction • Spirometric measurement of post-bronchodialator FEV1 is essential for assessment of severity (staging), to predict the outcome and to plan treatment. • The six-minute walk test (6MWT) is a simple, objective, and reproducible measurement of functional capacity of patients with chronic cardio-pulmonary impairment. • As per ATS guideline 6MWT is more reproducible than post-bronchodialator FEV1 • Spirometry is not available everywhere particularly in the rural areas of our country. • 6MWT is easy to perform and may be done at almost any set-up.
Background • Spirometry is of immense help in the diagnosis, staging and management of COPD but it is not available in most of the rural set-ups in India. • 6MWT is a simple, reproducible test and can be performed by majority of patients who are unable to perform spirometry and areas where spirometry is not available. • There are many studies conducted world wide showing 6MWT correlated well with different spirometric indices particularly post-bronchodialator FEV1 in predicting severity of COPD1,3. • One Indian study by Mehta et al2 also showed definite correlation between spirometric indices and 6MWD.
Inclusion Criteria • COPD patients attending OPD diagnosed by clinical and spirometric criteria (post bronchodilator FEV1 / FVC ratio <70%) as per GOLD CRITERIA
Exclusion Criteria • Unstable patient as per clinical assessment. • Patient with clinical or radiological evidence of Pneumonia. • Patient with Blood Pressure ≥ 180/100mmHg and resting heart rate >120/min prior to 6 MWT. • Those with evidence of left ventricular failure (LVF), ischemic heartdisease (IHD) or any major cardiac disease. • Abnormal ECG. • Neuromuscular disease of the lower extremities. • Peripheral Vascular Disease. • Those who refuse to give informed written Consent.
Mean and standard deviation of 6MWD values among different GOLD staging
Correlation of PEFR and 6MWD ANOVA F= 15.622 R = 0.408, p<0.001
Conclusion • Hence 6MWT may be done as a substitute for spirometry.
Limitation of the Study • Sample size is small • No control was taken
References • RoozbehNaghshin, Mohammad MassoodZaker, and AminEhteshamiAfshar. Association between Six-Minute Walk Test and Expiratory Spirometry Parameters in Chronic Obstructive Pulmonary Disease. Iranian Heart Journal 2005; 6 (3): 59-63 • Mehta Asmita, KumariIndira K.S. Correlation of Six Minute Walk Test with Spirometry and DLCO in Chronic Respiratory Diseases: Pulmon 2011;13(2). • C. Casanova, C.G. Cote et al. The 6-min walking distance: long-term follow up in patients with COPD. EurRespir J 2007; 29: 535–540.